SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001193125-20-234651
Filing Date
2020-08-28
Accepted
2020-08-28 16:02:49
Documents
13

Document Format Files

Seq Description Document Type Size
1 F-3 d54708df3.htm F-3 749156
2 EX-4.1 d54708dex41.htm EX-4.1 89547
3 EX-4.6 d54708dex46.htm EX-4.6 296192
4 EX-4.7 d54708dex47.htm EX-4.7 331607
5 EX-5.1 d54708dex51.htm EX-5.1 13389
6 EX-5.2 d54708dex52.htm EX-5.2 37786
7 EX-16.1 d54708dex161.htm EX-16.1 2087
8 EX-23.1 d54708dex231.htm EX-23.1 2099
9 GRAPHIC g54708g0827233837125.jpg GRAPHIC 2142
10 GRAPHIC g54708g13g36.jpg GRAPHIC 18660
11 GRAPHIC g54708g23p08.jpg GRAPHIC 41413
12 GRAPHIC g54708g87l80.jpg GRAPHIC 6736
13 GRAPHIC g54708goodwinlogo.jpg GRAPHIC 6086
  Complete submission text file 0001193125-20-234651.txt   1627111
Mailing Address RUE EDOUARD BELIN 12 MONT-SAINT-GUIBERT C9 1435
Business Address RUE EDOUARD BELIN 12 MONT-SAINT-GUIBERT C9 1435 32 10 394 100
Celyad Oncology SA (Filer) CIK: 0001637890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C9 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-248464 | Film No.: 201147851
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences